Dexcom (DXCM) EPS (Weighted Average and Diluted) (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.88% |
| Dec 31, 2025 | -4.29% |
| Sep 30, 2025 | 55.56% |
| Jun 30, 2025 | 66.67% |
| Mar 31, 2025 | -28.95% |
| Dec 31, 2024 | 11.76% |
| Sep 30, 2024 | -2.86% |
| Jun 30, 2024 | -2.78% |
| Mar 31, 2024 | -40.98% |
| Dec 31, 2023 | 110.34% |
| Sep 30, 2023 | 3.57% |
| Jun 30, 2023 | 133.33% |
| Mar 31, 2023 | -45.45% |
| Dec 31, 2022 | -8.33% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | -47.83% |
| Mar 31, 2022 | 2,400.00% |
| Dec 31, 2021 | -104.76% |
| Sep 30, 2021 | 10.53% |
| Jun 30, 2021 | -66.07% |
| Mar 31, 2021 | 660.00% |
| Dec 31, 2020 | -113.70% |
| Sep 30, 2020 | 52.08% |
| Jun 30, 2020 | 128.57% |
| Mar 31, 2020 | -79.00% |
| Dec 31, 2019 | 100.00% |
| Sep 30, 2019 | 516.67% |
| Jun 30, 2019 | 60.00% |
| Mar 31, 2019 | 85.22% |
| Dec 31, 2018 | -490.38% |
| Sep 30, 2018 | 52.94% |
| Jun 30, 2018 | 221.43% |
| Mar 31, 2018 | -154.55% |
| Dec 31, 2017 | -450.00% |
| Sep 30, 2017 | -166.67% |
| Sep 30, 2015 | -960.00% |
| Sep 30, 2014 | 11.11% |
| Sep 30, 2013 | 42.86% |